TABLE 1.
Sample characteristics at baseline, given as number and proportion for categorical characteristics and as mean and standard deviation for quantitative characteristics.
|
Phase 1
|
Phase 2
|
|||||
| Characteristics | Control n = 119 | ABM n = 125 | Control + Control n = 60 | ABM + Control n = 60 | Control + ACT n = 59 | ABM + ACT n = 65 |
| Gender | ||||||
| Males | 32 (26.9) | 34 (27.2) | 17 (28.3) | 16 (26.7) | 15 (25.4) | 18 (27.7) |
| Females | 87 (73.1) | 91 (72.8) | 43 (71.7) | 44 (73.3) | 44 (74.6) | 47 (72.3) |
| Age | 38.0 (12.7) | 38.8 (12.4) | 36.5 (13.1) | 35.3 (12.2) | 39.6 (12.2) | 42.0 (11.8) |
| Education | ||||||
| Lower than | 34 (28.6) | 30 (24.0) | 9 (15.0) | 8 (13.3) | 25 (42.4) | 22 (33.8) |
| university | 78 (65.5) | 87 (69.6) | 45 (75.0) | 46 (76.7) | 33 (55.9) | 41 (63.1) |
| University or higher | 7 (5.9) | 8 (6.4) | 6 (10.0) | 6 (10.0) | 1 (1.7) | 2 (3.9) |
| Missing | ||||||
| Antidepressants | ||||||
| No | 81 (68.1) | 85 (68.0) | 41 (68.3) | 45 (75.0) | 40 (67.8) | 40 (61.5) |
| Yes | 35 (29.4) | 36 (28.8) | (31.7)19 | 15 (25.0) | 16 (27.1) | 21 (32.3) |
| Missing | 3 (2.5) | 4 (3.2) | − | − | 3 (5.1) | 4 (6.2) |
| Comorbidity No | 47 (39.5) | 53 (42.4) | 21 (35.0) | 15 (25.0) | 26 (44.1) | 38 (58.5) |
| Yes | 72 (60.5) | 72 (57.6) | 39 (65.0) | 45 (75.0) | 33 (55.9) | 27 (41.5) |
| Episodes depression | 5.4 (6.7) | 6.1 (8.6) | 4.8 (6.3) | 4.8 (7.9) | 5.9 (7.1) | 7.2 (9.1) |
| Missing | 1 (0.1) | 1 (0.1) | − | 1 (1.7) | 1 (1.7) | − |
| BDI-II score | 16.9(10.9) | 19.0 (19.5) | 12.8 (8.3) | 16.0 (11.0) | 21.5 (11.7) | 22.3 (9.0) |
| Missing | 5 (4.2) | 10 (8.0) | − | − | 5 (8.5) | 10 (15.4) |
| HRSD score | 9.5 (5.6) | 9.4 (6.2) | 8.4 (4.7) | 9.7 (6.4) | 10.7 (6.3) | 9.2 (6.0) |
| Missing | 3 (2.5) | − | − | − | 3 (5.1) | − |